Medicinal Products

Lenalidomid Krka

The medicinal product has been authorised by the European Commission (EC) via centralised procedure in all EU Member States, based on the European Medicines Agency (EMA) experts' opinion.

Name Lenalidomid Krka
Former Name Lenalidomid Krka d.d. Novo mesto
Active Substance lenalidomidklorid hidrat
Prescription Medicinal product subject to medical prescription
Type of prescription ograničeni recept
Distribution Supply through pharmacies (community)
ATC Code L04AX04
Marketing status nije stavljeno u promet
Summary of product characteristics (SmPC), labelling and package leaflet (PL) download
Link to the European Medicines Agency's (EMA) product information download
Link to the European Commission's (EC) decisions download

Packaging

Back